Literature DB >> 4650368

Experimental myasthenia in mice. The role of the thymus and lymphoid cells.

S Kawanami, R Mori.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4650368      PMCID: PMC1553615     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  15 in total

1.  Experimental autoimmune thymitis. An animal model of human myasthenia gravis.

Authors:  G Goldstein; S Whittingham
Journal:  Lancet       Date:  1966-08-06       Impact factor: 79.321

2.  Experimental myasthenia gravis.

Authors:  J R Kalden; W J Irvine
Journal:  Lancet       Date:  1969-09-20       Impact factor: 79.321

3.  Experimental myasthenia gravis.

Authors:  J M Vetters; J A Simpson; A Folkarde
Journal:  Lancet       Date:  1969-07-05       Impact factor: 79.321

4.  Antigens in thymus and muscle effective in inducing experimental autoimmune thymitis and the release of thymin.

Authors:  G Goldstein; A J Strauss; S Pickeral
Journal:  Clin Exp Immunol       Date:  1969-01       Impact factor: 4.330

5.  Experimental studies related to autoimmunity in myasthenia gravis.

Authors:  B M Kaufman; G Rushworth; R Wright
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-08       Impact factor: 10.154

6.  Histological and serological features of experimental autoimmune thymitis in guinea-pigs.

Authors:  G Goldstein; S Whittingham
Journal:  Clin Exp Immunol       Date:  1967-05       Impact factor: 4.330

7.  Electrophysiological changes similar to those of myasthenia gravis in rats with experimental autoimmune thymitis.

Authors:  G Goldstein; W W Hofmann
Journal:  J Neurol Neurosurg Psychiatry       Date:  1968-10       Impact factor: 10.154

8.  Endocrine function of the thymus affecting neuromuscular transmission.

Authors:  G Goldstein; W W Hofmann
Journal:  Clin Exp Immunol       Date:  1969-02       Impact factor: 4.330

9.  The thymus and neuromuscular function. A substance in thymus which causes myositis and myasthenic neuromuscular block in guineapigs.

Authors:  G Goldstein
Journal:  Lancet       Date:  1968-07-20       Impact factor: 79.321

10.  Thymitis and myasthenia gravis.

Authors:  G Goldstein
Journal:  Lancet       Date:  1966-11-26       Impact factor: 79.321

View more
  6 in total

1.  Damage of skeletal muscle in rats by immunoglobulins. I. Pathophysiological data and lightmicroscopic observations.

Authors:  A Korényi-Both; G Kelemen
Journal:  Acta Neuropathol       Date:  1976-03-30       Impact factor: 17.088

2.  Cellular immune response to acetylcholine receptor-rich fraction, in patients with myasthenia gravis.

Authors:  O Abramsky; A Aharonov; C Webb; S Fuchs
Journal:  Clin Exp Immunol       Date:  1975-01       Impact factor: 4.330

3.  Induction of T-cell differentiation in vitro by thymin, a purified polypeptide hormone of the thymus.

Authors:  R S Basch; G Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

Review 4.  Progress in myasthenia gravis.

Authors:  C W Havard
Journal:  Br Med J       Date:  1973-08-25

5.  Leucocyte migration inhibition in myasthenia gravis. The effect of thymectomy.

Authors:  S Kawanami; Y Itoyama; Y Kuroiwa
Journal:  J Neurol       Date:  1976-07-15       Impact factor: 4.849

6.  Immunological relationship between acetylcholine receptor and thymus: a possible significance in myasthenia gravis.

Authors:  A Aharonov; R Tarrab-Hazdai; O Abramsky; S Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.